Literature DB >> 17018275

Nuclear signaling by receptor tyrosine kinases: the first robin of spring.

Joseph Schlessinger1, Mark A Lemmon.   

Abstract

The role of receptor tyrosine kinases (RTKs) in transmembrane signaling is well established. Recently, ligand-dependent translocation of RTKs to the nucleus has been reported, but the functional importance of this process remains unclear. In this issue, Sardi et al. (2006) provide evidence for direct signaling in the nucleus by an intracellular ErbB4 receptor fragment that is released upon receptor activation by ligand. The fragment forms a complex with the adaptor TAB2 and the corepressor N-CoR and transits to the nucleus, where it represses transcription of genes that promote the formation of astrocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018275     DOI: 10.1016/j.cell.2006.09.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  31 in total

1.  Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia.

Authors:  Kathrein von Kopylow; Hannah Staege; Wolfgang Schulze; Hans Will; Christiane Kirchhoff
Journal:  Histochem Cell Biol       Date:  2012-07-10       Impact factor: 4.304

Review 2.  Biological function of nuclear receptor tyrosine kinase action.

Authors:  Sungmin Song; Kenneth M Rosen; Gabriel Corfas
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 3.  Spatial regulation of receptor tyrosine kinases in development and cancer.

Authors:  Jessica B Casaletto; Andrea I McClatchey
Journal:  Nat Rev Cancer       Date:  2012-05-24       Impact factor: 60.716

Review 4.  Targeting inflammatory pathways for tumor radiosensitization.

Authors:  Amit Deorukhkar; Sunil Krishnan
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

5.  Targeting metastatic upper gastrointestinal adenocarcinomas.

Authors:  Jennifer L Spratlin; Quincy Chu; Sheryl Koski; Karen King; Karen Mulder
Journal:  World J Clin Oncol       Date:  2011-03-10

6.  Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study.

Authors:  Bei Yang; Haiping Zhang; Hao Wang
Journal:  J Mol Model       Date:  2015-01-27       Impact factor: 1.810

7.  Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.

Authors:  Jonathan W Haskins; Don X Nguyen; David F Stern
Journal:  Sci Signal       Date:  2014-12-09       Impact factor: 8.192

Review 8.  The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.

Authors:  Ranee Mehra; Roger B Cohen; Barbara A Burtness
Journal:  Clin Adv Hematol Oncol       Date:  2008-10

9.  Application of computational approaches to study signalling networks of nuclear and Tyrosine kinase receptors.

Authors:  Mouna Choura; Ahmed Rebaï
Journal:  Biol Direct       Date:  2010-10-11       Impact factor: 4.540

10.  HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.

Authors:  Menghong Sun; Carmen Behrens; Lei Feng; Natalie Ozburn; Ximing Tang; Guosheng Yin; Ritsuko Komaki; Marileila Varella-Garcia; Waun Ki Hong; Kenneth D Aldape; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.